Filtered By:
Condition: Diabetes
Infectious Disease: COVID-19
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 599 results found since Jan 2013.
Neurological Complications of the COVID-19 Pandemic: What Have We Got So Far?
Adv Exp Med Biol. 2021;1321:21-31. doi: 10.1007/978-3-030-59261-5_2.ABSTRACTThe recently emerged coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of COVID-19, is the newest threat to human health. It has already infected more than 54.5 million people worldwide, currently leading to more than 1.3 million deaths. Although it causes a mild flu-like disease in most patients, lethality may increase to more than 20% in elderly subjects, especially in those with comorbidities, like hypertension, diabetes, or lung and cardiac disease, and the mechanisms are still elusive. Common symp...
Source: Advances in Experimental Medicine and Biology - March 3, 2021 Category: Research Authors: Isabelle Pastor Bandeira Marco Ant ônio Machado Schlindwein Leticia Caroline Breis Jean Pierre Schatzmann Peron Marcus Vin ícius Magno Gonçalves Source Type: research
COVID-19 and Thromboinflammation: Is There a Role for Statins?
The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. There is also evidence of possible links among COVID-19, myocardial infarction, and stroke. Emerging evidence suggests a pro-inflammatory milieu and hypercoagulable state in patients with this infection. Despite anticoagulation, a large proportion of patients requiring intensive care may develop life-threatening thrombotic complications. Indeed, the levels of some marke...
Source: Clinics - March 24, 2021 Category: General Medicine Source Type: research
Assistance and health care provided to adolescents with chronic and immunosuppressive conditions in a tertiary university hospital during the COVID-19 pandemic
The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. There is also evidence of possible links among COVID-19, myocardial infarction, and stroke. Emerging evidence suggests a pro-inflammatory milieu and hypercoagulable state in patients with this infection. Despite anticoagulation, a large proportion of patients requiring intensive care may develop life-threatening thrombotic complications. Indeed, the levels of some marke...
Source: Clinics - March 24, 2021 Category: General Medicine Source Type: research
Post-coronavirus disease syndrome and disseminated microthrombosis: the role of the von Willebrand factor and antiphospholipid antibodies
The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. There is also evidence of possible links among COVID-19, myocardial infarction, and stroke. Emerging evidence suggests a pro-inflammatory milieu and hypercoagulable state in patients with this infection. Despite anticoagulation, a large proportion of patients requiring intensive care may develop life-threatening thrombotic complications. Indeed, the levels of some marke...
Source: Clinics - March 24, 2021 Category: General Medicine Source Type: research
The U.S. Death Rate Rose Significantly During the COVID-19 Pandemic
COVID-19 was the third-most-common cause of death in the U.S. in 2020, contributing to more than 375,000 deaths, and a 16% increase in the national death rate, according to provisional data published today by the U.S. Centers for Disease Control and Prevention (CDC).
All told, more than 3.3 million people in the U.S. died in 2020, for a rate of about 829 deaths per 100,000 people. That’s up from about 715 deaths per 100,000 people in 2019.
( function() {
var func = function() {
var iframe = document.getElementById('wpcom-iframe-cc2cb8dfd195b43a5d43643e9ec19ffa')
if ( iframe ) {
iframe.onload =...
Source: TIME: Health - March 31, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Cardiovascular injuries during COVID-19 infection: A PROCESS-compliant case series from the Eastern Morocco
CONCLUSION: Cardiovascular involvement during COVID-19 should not be neglected and are associated with severe outcomes.PMID:33898022 | PMC:PMC8053362 | DOI:10.1016/j.amsu.2021.102309
Source: Annals of Medicine - April 26, 2021 Category: Internal Medicine Authors: Abdelilah El Rhalete Inas Rhazi Amine Bensaid Ikram Zaid Houssam Bkiyer Nabila Ismaili Nouha Elouafi Brahim Housni Source Type: research
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland
CONCLUSION: Among cardiovascular risk factors and diseases, HF and DM appeared to increase in-hospital COVID-19 mortality, whereas the use of cardiovascular drugs was associated with lower mortality.PMID:33926173 | DOI:10.33963/KP.15990
Source: Polish Heart Journal - April 30, 2021 Category: Cardiology Authors: Micha ł Terlecki Wiktoria Wojciechowska Marek Klocek Agnieszka Olszanecka Katarzyna Stolarz-Skrzypek Tomasz Grodzicki Maciej Ma łecki Barbara Katra Aleksander Garlicki Monika Boci ąga-Jasik Krzysztof S ładek Andrzej Matyja Jerzy Wordliczek Agnieszka S Source Type: research
